276°
Posted 20 hours ago

BONDOX HAIR TREATMENT (Brazilian (250 g))

£10.8£21.60Clearance
ZTS2023's avatar
Shared by
ZTS2023
Joined in 2023
82
63

About this deal

Giesler M (2012). "How Doppelgänger Brand Images Influence the Market Creation Process: Longitudinal Insights from the Rise of Botox Cosmetic". Journal of Marketing. 76 (6): 55–68. doi: 10.1509/jm.10.0406. S2CID 167319134. a b c Walker TJ, Dayan SH (February 2014). "Comparison and overview of currently available neurotoxins". The Journal of Clinical and Aesthetic Dermatology. 7 (2): 31–39. PMC 3935649. PMID 24587850. Botulinum Toxin Type A Product Approval Information - Licensing Action 4/12/02". U.S. Food and Drug Administration (FDA). 9 February 2009. Archived from the original on 13 January 2017 . Retrieved 18 December 2022. Satriyasa BK (10 April 2019). "Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect". Clinical, Cosmetic and Investigational Dermatology. 12: 223–228. doi: 10.2147/CCID.S202919. PMC 6489637. PMID 31114283.

a b c d "About Botulism | Botulism | CDC". www.cdc.gov. 9 October 2018. Archived from the original on 27 April 2020 . Retrieved 13 May 2020. a b Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, etal. (October 2005). "Botulinum neurotoxin detection and differentiation by mass spectrometry". Emerging Infectious Diseases. 11 (10): 1578–1583. doi: 10.3201/eid1110.041279. PMC 3366733. PMID 16318699. Botulism". Centers for Disease Control and Prevention (CDC). 19 August 2019. Archived from the original on 3 August 2016 . Retrieved 28 August 2019.

Our Network

Overview of all the structural information available in the PDB for UniProt: A0A0X1KH89 (Bontoxilysin A) at the PDBe-KB. In the case of treatment of infantile esotropia in people younger than 12 years of age, several studies have yielded differing results. [56] [139] Cosmetic [ edit ] JD and JA Carruthers also studied and reported in 1992 the use of botulinum toxin type-A as a cosmetic treatment.[78] They conducted a study of participants whose only concern was their glabellar forehead wrinkle or furrow. Study participants were otherwise normal. Sixteen of seventeen participants available for follow-up demonstrated a cosmetic improvement. This study was reported at a meeting in 1991. The study for the treatment of glabellar frown lines was published in 1992. [107] This result was subsequently confirmed by other groups (Brin, and the Columbia University group under Monte Keen [140]). The FDA announced regulatory approval of botulinum toxin type A (Botox Cosmetic) to temporarily improve the appearance of moderate-to-severe frown lines between the eyebrows (glabellar lines) in 2002 after extensive clinical trials. [141] Well before this, the cosmetic use of botulinum toxin type A became widespread. [142] The results of Botox Cosmetic can last up to four months and may vary with each patient. [143] The US Food and Drug Administration (FDA) approved an alternative product-safety testing method in response to increasing public concern that LD50 testing was required for each batch sold in the market. [144] [145] Pacik PT (December 2009). "Botox treatment for vaginismus". Plastic and Reconstructive Surgery. 124 (6): 455e–456e. doi: 10.1097/PRS.0b013e3181bf7f11. PMID 19952618.

Botulinum toxin is used to treat a number of therapeutic indications, many of which are not part of the approved drug label. [21] Muscle spasticity [ edit ] Alam M, et al. (2015). Multicenter prospectivecohort study of the incidence of adverse events associated with cosmetic dermatologicprocedures: Lasers, energy devices, and injectable neurotoxins and fillers. DOI: Xeomin 50 units powder for solution for injection - Summary of Product Characteristics (SmPC)". (emc). 28 July 2022. Archived from the original on 18 December 2022 . Retrieved 18 December 2022. Clinical trial number NCT01917006 for "An Exploratory Study of the Safety and Efficacy of Botox for the Treatment of Premature Ejaculation" at ClinicalTrials.gov Sialorrhea is a condition where oral secretions are unable to be eliminated, causing pooling of saliva in the mouth. This condition can be caused by various neurological syndromes such as Bell's palsy, intellectual disability, and cerebral palsy. Injection of botulinum toxin type-A into salivary glands is useful in reducing the secretions. [150] Cervical dystonia [ edit ]

What is Botox used for?

Once you’ve had Botox injected, the effects on the muscles usually become apparent within a few hours, with the main effects appearing after about a week. Are the injections safe? This section needs additional citations for verification. Please help improve this article by adding citations to reliable sourcesin this section. Unsourced material may be challenged and removed. ( August 2018) ( Learn how and when to remove this template message)

While most side effects of Botox are temporary and resolve on their own, there are some potential long-term risks to consider. Frequent Botox injections over an extended period may cause permanent changes to facial expressions or the inability to make certain facial movements. To minimize these risks, ensure you receive Botox injections from a licensed healthcare provider or clinic with proper training. Managing Botox Side Effects Revance Announces FDA Approval of Daxxify (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results" (Press release). Revance. 8 September 2022. Archived from the original on 10 September 2022 . Retrieved 24 September 2022– via Business Wire.

In December 1989, Botox was approved by the US FDA for the treatment of strabismus, blepharospasm, and hemifacial spasm in people over 12 years old. [102]

Asda Great Deal

Free UK shipping. 15 day free returns.
Community Updates
*So you can easily identify outgoing links on our site, we've marked them with an "*" symbol. Links on our site are monetised, but this never affects which deals get posted. Find more info in our FAQs and About Us page.
New Comment